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SUMMARY
Abnormal uterine bleeding is a common gynaecological symptom. Whilst most patients have
benigndisease,thoroughinvestigationisnecessary,particularlyintheperi-andpost-menopausal
woman.Hysteroscopywithdirectedbiopsyofsuspiciouslesionsisthegoldstandardinvestigation
but it is invasive and is not offered in all units as an outpatient procedure. Ultrasound and
outpatientbiopsy techniques may allowpatients to be triaged to selectthose who requireformal
evaluation by hysteroscopy.
We assessed the records of 100 consecutive referrals to the outpatient hysteroscopy clinic at the
Royal Maternity Hospital, Belfast. In order to develop a nomogram for the investigation of
women with abnormal bleeding patterns, we compared ultrasound/biopsy diagnoses with
hysteroscopy/biopsydiagnosis.Pre-andperi-menopausalpatients,andpost-menopausalpatients
takinghormonereplacementtherapyshouldbeinvestigatedfurtheriftheendometrialthickness
is more than 10 mm, ifendometrial biopsy is abnormal, orifsymptoms are recurrent. Similarly,
post-menopausalpatientsnottakinghormonereplacementtherapywithanendometrialthickness
of5 mm or more should be referred for hysteroscopy.
INTRODUCTION
Abnormal uterine bleeding is a common
gynaecological symptom. In peri- and post-
menopausal women it is essential to exclude
endometrial carcinoma although the incidence is
only6.96per 1000womenwithpostmenopausal
bleeding.' In younger women, endometrial
hyperplasia and anatomical anomalies, such as
uterine fibroids, comprise the main pathology.2
The recommendation regarding investigation of
abnormaluterinebleedingfromtheRoyalCollege
of Obstetricians and Gynaecologists is that
women,overtheageof45, shouldbeinvestigated
with hysteroscopy and endometrial biopsy.3
Frequently, this is performed as an inpatient
procedure with the biopsy being obtained by
uterine curettage (D&C). Blind sharp curettage
covers asmuchas60% ofthecavitybutmaymiss
polyps as they recoil from the passing curette.4
However, inpatient investigations are costly and
there are risks associated with the use ofgeneral
anaesthesia.
Outpatient alternatives to D&C include
microhysteroscopy (either flexible or rigid),
transvaginal ultrasonography, with or without
saline infusion (sonohysterography) and
endometrial biopsy. Transvaginal ultra-
sonography is useful in determining endometrial
thicknessandmorphologyaswellastheregularity
of the endo/myometrial border.' Whilst the
procedure is well toleratedbypatients, sessile or
pedunculated lesions of the endometrium and
malignant disease cannot be definitively
excluded.6 7 However, it has been reported that
post-menopausal malignant disease is very
unlikely when the endometrial thickness is less
than 5 mm and the patient is not taking hormone
replacement therapy (HRT).8 Vaginal
sonohysterography is a modification of vaginal
ultrasound in which a small volume of saline is
injectedintotheuterinecavityduringultrasound
examination.9 This enables irregularities of the
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endo/myometrialborderandthefreeendometrial
border to be more easily visualised.10
Outpatient endometrial sampling devices have a
narrow bore (typically about 3 mm external
diameter) and sample the endometrium by
aspiration. Although they pass relatively easily
throughthecervicalcanal,theremaybeassociated
pain when the sample is harvested and, unlike
directed biopsy, the sample is obtainedblind. As
little as 4% of the cavity may be sampled and
polypoid lesions are unlikely to be removed.11
However, the reported sensitivity for detecting
endometrial abnormality is approximately
85% 12, 13
Outpatient hysteroscopy is both feasible and
highly acceptable in the majority of patients,
giving a high detection rate for intrauterine
pathology.'4"5 It allows the operator to take a
directedbiopsyandismorespecificandsensitive
thantransvaginalultrasoundorblindendometrial
sampling.Asaninvestigationforabnormaluterine
bleeding it was recommended by both the Royal
CollegeofObstetricians andGynaecologists and
the American College of Obstetricians and
Gynecologists in 1994.3 16 However, it is
significantly less easily performed than either
ultrasound or biopsy. Therefore, a means of
selecting patients by, for example, menopausal
status, symptomatology and associated clinical
findings might lead to a more efficient use of
hysteroscopythanablanketrecommendationthat
all cases of abnormal bleeding should undergo
the procedure.
Our aim was to develop a nomogram using
historical information, ultrasound and biopsy
results to select those women who should have a
formal hysteroscopic evaluation.
METHODS
The charts of 100 consecutive referrals for
outpatient hysteroscopy from the general
gynaecology clinics at the Royal Group of
Hospitals' Trust, Belfast, were reviewed. The
decision to refer was made by the patient's
consultant: there were no defined guidelines for
referral: a number of patients had vaginal
ultrasound scan and endometrial biopsy at the
outpatientclinicpriortoreferral(theseprocedures
were repeated at the outpatient hysteroscopy
clinic). The indication for the procedure, the
subject'sage,parity,menstrualstatusandoutcome
of the investigation were recorded. All of the
procedures wereperformed by a single operator.
Whilstthedatawasrecordedprospectively atthe
time of consultation it was analysed
retrospectively.
The examination of each subject followed a
standard protocol. The patient was placed in the
lithotomy position with her ankles supported by
stirrups. A bimanual vaginal examination was
performed to note the size, position and shape of
theuterus andthepresenceorabsence ofadnexal
pathology.Vaginalultrasoundexaminationusing
a5 MHzprobe (FFSonic,FukudaDenshi,Japan)
wasperformedtodeterminethedualendometrial
thickness (ET),thatis,theperpendiculardistance
from one endo/myometrial borderto the other at
its widest part in longitudinal section, and to
identify endometrial polypoid lesions, free fluid
or fibroids.
For the hysteroscopy a Simm's speculum was
inserted into the vagina and the cervix grasped
with a single toothed tenaculum forceps. A 3.4
mmexternaldiameterHamouMicrohysteroscope
(Karl Storz, Tuttlingen, Germany) was passed
through the cervix, under direct vision, into the
uterine cavity which was distended by carbon
dioxide via a hysteroflator (Karl Storz) set at
maximum pressure 75 mmHg and flow rate of
200 mls/minute. Thecavity was illuminatedby a
Coldlight Fountain (Karl Storz) and the images
displayed on a Sony Trinitron monitor using a
Telecam Pal single chip camera system (Karl
Storz). The endometrium was serially inspected
forpathology. When the inspection ofthe cavity
was complete the gas and scope were removed
from the uterus.
Finally, a Pipelle endometrial sampler was used
to obtain a biopsy of the endometrium using no
morethantwo attempts atsampleaspiration. The
specimen was placed in formalin and sent for
histopathological analysis. Neither analgesia or
anaesthesia was routinely used and was not
required by any patient in this series.
The histological and ultrasound diagnoses were
combined to formulate a working ultrasound/
biopsy diagnosis and this was compared with a
similarly combined hysteroscopy/biopsy
diagnosis.
RESULTS
The average age ofthepatients referred was 48.5
years (29-78). Six subjects were nulliparous, six
weregrandmultiparas andtheremainderhadhad
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Table I
Comparison ofhysteroscopy/biopsy and transvaginal scanning/biopsy diagnoses in
postmenopausalpatients
Hysteroscopy/biopsy Ultrasound/biopsy Ultrasound/biopsy
diagnosis diagnosis concordant diagnosis discordant
Normal 16 0
Atrophy 16 1 endometrial polyp
Endometrial polyp 2 2 normal cavity
Endocervical polyp 0 3 normal uterus
Neoplasm 1 0
between one and five vaginal deliveries. Of the
100 patients, it was not possible to perform
outpatient hysteroscopy in two cases. Both were
post-menopausal and subsequently underwent
hysteroscopy under general anaesthesia. In one
of these patients the uterus was anteverted and
acutely anteflexed, in the other, access to the
vaginal vault and cervix was impossible and a
diagnosis of erosive vaginal lichen planus was
eventually made. These two patients were not
considered further in the analysis.
Ninetytwo(94%)patientshadendometrialbiopsy
samples which were adequate for histological
diagnosis. The six patients whose biopsies were
not adequate for diagnosis had atrophic
endometrium diagnosed both by hysteroscopy
and scanning.
Forty-one (41.8%) of the patients were post-
menopausal and, ofthese, 25 (61%) were using
hormone replacement therapy. In 35 of the 41
subjects(85.4%)thehysteroscopicdiagnosiswas
in agreement with the ultrasound diagnosis.
Thirty-two (78%) had a diagnosis of a normal
cavity or of atrophy, two (4.9%) of benign
endometrialpolypsandone(2.4%)ofendometrial
cancer (endometrialthickness20mmonscanning
and copious blood clot within the cavity on
hysteroscopy). Of the remaining six (14.6%),
three had normal ultrasound and biopsy but
endocervical polyps were noted at hysteroscopy
(two HRT users), one ofwhom also had a small
endometrialpolyp(endometrialthickness>5mm
in all three). Three further subjects had
endometrial polyps in isolation noted on
hysteroscopy (one HRT user), two ofwhom had
an endometrial thickness >6 mm (summarised in
Table I) and one a diagnosis of atrophy on the
basis of the ultrasound biopsy findings
(endometrial thickness 3 mm, HRTuser). Use of
HRT was associated with a non-significant
increaseinETon scanning (averageET: noHRT
3.9 mm, HRT5.8 mm, p=0.23) andpatients were
nomorelikelytohaveendometrialorendocervical
pathology ifusing HRT.
Ofthe 57 peri- and pre-menopausal patients the
ultrasound/biopsy and hysteroscopy/biopsy
diagnoses were concordant in 52 (91%). There
were50(87%)caseswithanormalcavity,atrophy
orsmallfibroidsnotcausingsignificantdistortion
ofthecavity,one(2%)caseofbenignhyperplasia
and one (2%) endometrial polyp.
Two further cases of endocervical polyps (both
with ET >10 mm), one (2%) sub-septate uterus
and one (2%) endometrial polyp (ET 12 mm)
were diagnosed with hysteroscopy but not with
ultrasound and one (2%) case of suspected
neoplasm on ultrasound (but not on biopsy) was
found to have a benign fibroid at hysteroscopy
Table II). No endometrial or endocervical
pathology was detected in any pre- or peri-
menopausal patient with an ET of less than 11
mm. However, in postmenopausal patients with
an ET of 5 mm or less one patient had a small
endometrial polyp noted at hysteroscopy.
In total, the diagnoses were concordant in 87
(89%) cases. Five cases ofendocervical andfour
cases of endometrial polyps were noted at
hysteroscopy but not at ultrasound/biopsy. If
hysteroscopy/biopsyistakenasthegoldstandard
the overall sensitivity of transvaginal scanning
combined with biopsy is 75% for endometrial
pathology with a specificity of 90% (positive
predictive value 40%, negative predictive value
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Table II
Comparison ofhysteroscopy/biopsy and transvaginal scanning/biopsy diagnoses inpre- and
perimenopausalpatients
Hysteroscopy/biopsy Ultrasound/biopsy Ultrasound/biopsy
diagnosis diagnosis concordant diagnosis discordant
Normal 40 0
Fibroids 9 1 suspected neoplasm
Endometrial polyp 1 1 normal uterus
Endocervical polyp 0 2 normal uterus
Huperplasia 1 0
Septum 0 1 normal uterus
Atrophy 1 0
98%). When a cut-off value of 5 mm for ET in
post-menopausalwomennottakingHRTistaken,
vaginal ultrasound/biopsy achieved a sensitivity
of100%. The 10mmETcutoffforpre-,peri- and
postmenopausal womentakingHRT, has alower
sensitivity,however,thepositivepredictivevalue
is increased (i.e. whenpathology was diagnosed,
it was more often present).
DISCUSSION
This is the first prospective comparison of
transvaginal ultrasound with biopsy versus
outpatient hysteroscopy with biopsy in a patient
population with both pre- and postmenopausal
patients. A single operatorwhohadconsiderable
experienceineachtechniqueperformedallofthe
procedures. The subject body constituted 100
consecutivereferrals fromsevengynaecologists:
the decision to refer was taken by the clinicians
on an individual basis and no specific criteria
were set. Thepatientsincludedwerethosewhom
the referring gynaecologists felt were likely to
have pathology and to require a more thorough
evaluation than could be offered by ultrasound
and biopsy alone. As the purpose of this study
was to develop a nomogram for evaluation of
patients with abnormal pre- or postmenopausal
bleeding, wefeelthatthis enhancedthepowerof
the study by including only those likely to have
pathology.
Intheliteraturetodate,therehavebeennumerous
reports examining the role of ultrasound or
hysteroscopybutwithoutbiopsy.Biopsyislikely
to miss polyps and fibroids whilst ultrasound is
likelytoidentifyintramuralfibroidsbutbeunable
todifferentiatebetweenendometrialhyperplasia,
endometrial polyps and early cancers.
Hysteroscopy can identify discrete lesions but
doesnotgiveahistologicaldiagnosis. Therefore,
any effective clinical service is likely to require
all three methods of investigation. However,
hysteroscopy is expensive in comparison and
requires considerable operator skill.
In this study, the evaluation of the post-
menopausal group suggests that if the
endometriumisthin(<5 mm)thelikelydiagnosis
is atrophy and this can be confirmed by
endometrial sampling although caution must be
exercisedwhenaninadequatebiopsyisreported.17
If atrophy is diagnosed, oestrogen replacement
may alleviate symptoms. If bleeding recurs
hysteroscopy should be performed. By contrast,
if the ET is >5 mm then formal hysteroscopic
evaluation is indicated.
In the group of postmenopausal women using
HRT, an ET of more than 10 mm (even with a
normalbiopsy) is anindicationforhysteroscopy.
In women with normal biopsy and ET 10 mm or
less a period of observation is acceptable but if
furtherbleedingoccurs,referralforhysteroscopy
should be made. The advantage of the raise in
limit for those taking HRT is that the number of
unnecessary hysteroscopies will be decreased.
For pre-menopausal patients changes in
endometrial thickness throughout the menstrual
cycle may cause confusion. Although ET
commonly exceeds 10 mm in normal uteri,
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becauseofthedifficultyindifferentiatingbetween
polyps,hyperplasiaandfibroidpolyps, webelieve
thatETgreaterthan 10mmshouldleadtoreferral
forhysteroscopyinwomenwithabnormaluterine
bleeding. If, at ultrasound, the cavity appears
distorted by submucosal fibroids, the only
indication for hysteroscopy is to assess their
suitability for hysteroscopic resection.
Our findings largely support those previously
reported.18 For example, Guidot 12 and Schei 4
have shown that micro-curettage alone is not a
safe alternative to hysteroscopy as polyps are
often missed and may contain focal hyperplastic
ormalignantchange.Wehaverefinedthisfurther
to demonstrate that, in combination with
ultrasound and with the provisos given above,
hysteroscopy can often be safely avoided.
However, an abnormal histological report on a
biopsy specimen in a woman of any age, or
persistent abnormal uterine bleeding, should
prompt urgent referral for hysteroscopy.
WhilstNaegele etall 4suggestedthatoutpatient
hysteroscopy may become a routine procedure
(as ultrasound presently is in some units) the
financial implications of such a shift in clinical
practice would be huge and a large number of
unnecessaryprocedureswouldbeperformed.The
guidelines of both the American and Royal
Colleges of Obstetricians and Gynaecologists
are less radical in their enthusiasm for
hysteroscopy and suggest appropriate patient
selection. Guidelines tor such patient selection
haveyettobedrawnup atanationallevelandwe
believe that a significant number of procedures
arebeingperformedwithoutadequateindication.
Hysteroscopy is well tolerated by women and is
an important adjunct to clinical examination,
transvaginalultrasoundscanningandendometrial
biopsy. However, as the most invasive of the
procedures it should be reserved for those cases
whereitisclearlyindicatedratherthanappliedto
all cases.
Nomogram
Abnormal Uterine Bleeding
Pre menopausal or Post menopausal
Post menopausal on HRT
l4l
TVUSS endometrial thickness TVUSS endometrial thickness
/ \) \
211mm <1SOmm .5mm .6mm
with normal biopsy with nor Salbioy with no al biopsy with normal biops)
NO HYSTEROSCOPY
Any abnormal histopathology onbiopsy
irrespective ofendometrial thickness
tamoxifen therapy, or
recurrent symptoms
HYSTEROSCOPY
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